• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCICENCS IMPLANTS SA GRAVITY COMPENSATING ACCESSORY,MEDIUM; ANTI-SIPHON DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCICENCS IMPLANTS SA GRAVITY COMPENSATING ACCESSORY,MEDIUM; ANTI-SIPHON DEVICE Back to Search Results
Catalog Number 903435
Device Problems No Device Output (1435); Use of Device Problem (1670)
Patient Problems Ambulation Difficulties (2544); Hydrocephalus (3272)
Event Date 09/14/2016
Event Type  Injury  
Event Description
On (b)(6) 2016 a (b)(6) female patient had the 903435 gravity compensating accessory implanted along with a fixed pressure valve.In the weeks following this surgery, specifically around (b)(6) 2016 the patient was experiencing difficulty with her gait and a scan was performed.The scanner detected hydrocephalus, suggesting that the gravity compensating accessory was not allowing the cerebrospinal fluid (csf) to drain.To solve this situation, it was necessary to surgically remove the gravity compensating accessory and implant a programmable valve.This took place on (b)(6) 2016.The programmable valve was a polaris spva valve, manufactured by sophysa.The hydrocephalus has been stabilized.
 
Manufacturer Narrative
Investigation completed 3/01/2017.Method: -dhr review, -trend analysis, - failure analysis.The device history records review of the gca ref 903435, lot 193322 were reviewed and did not reveal any anomaly.The batch was manufactured in january 2016 and included (b)(4) products.No similar complaint was received for a product from this batch.A review of integra complaint tracking database since january 2014 revealed no other complaint.No trend is observed visual inspection under magnification of the gravity compensating accessory (gca) revealed no anomaly that could explain the reported blockage.The gca was pressure/flow tested in both horizontal and vertical positions and found within specifications.The complaint is not verified on the received gca, the device investigation does not allow to explain the reported obstruction.Conclusion: the gca is implanted in series with a hydrocephalus valve to control cerebrospinal fluid drainage from the cerebral ventricles to an appropriate drainage site.The gca is designed to counterbalance gravity¿s effects on the fluid column within the out¬flow (drainage) catheter of an implanted shunt system.The reported insufficient drainage, a few weeks after implantation, is linked to the system (valve + gca) and may be related to several reasons: as the gca was found within specifications, the insufficient drainage may be linked to the valve malfunction (or not suited to the patient), or to the choice of gca operating characteristics (too much resistance added).Obstruction of the hydrocephalus valve system (with antigravity system or not) is a known complication of valve therapy, as indicated in the gca instructions for use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAVITY COMPENSATING ACCESSORY,MEDIUM
Type of Device
ANTI-SIPHON DEVICE
Manufacturer (Section D)
INTEGRA NEUROSCICENCS IMPLANTS SA
2905 route des dolines
2905 route des dolines
sophia antipolis F-069 21
FR  F-06921
Manufacturer (Section G)
INTEGRA NEUROSCICENCS IMPLANTS SA
2905 route des dolines
sophia antipolis F-069 21
FR   F-06921
Manufacturer Contact
rowena bunuan
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key6238512
MDR Text Key64431907
Report Number9612007-2017-00002
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K152897
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number903435
Device Lot Number0193322
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/31/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received03/01/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age79 YR
-
-